Page 64 - IMO-2-3

Innovative Medicines & Omics Biocompatibility of nanomaterials

3D-printed scaffold technologies for bone defect repair: 53. Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for
Materials, biomechanics, and clinical prospects. BioMed mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094.
Eng Online. 2025;24:51.
doi: 10.1038/s41578-021-00358-0
doi: 10.1186/s12938-025-01381-w
54. Rasmussen K, Rauscher H, Kearns P, González M, Sintes
49. Tao Z, Yuan Z, Zhou D, et al. Fabrication of magnesium JR. Developing OECD test guidelines for regulatory testing
doped porous polylactic acid microsphere for bone of nanomaterials to ensure mutual acceptance of test data.
regeneration. Biomater Transl. 2023;4(4):280-290. Regul Toxicol Pharmacol. 2019;104:74-83.
doi: 10.12336/biomatertransl.2023.04.007 doi: 10.1016/j.yrtph.2019.02.008
50. Jain KK. Nanomedicine: Technologies and Applications. 55. Germain M, Caputo F, Metcalfe S, et al. Delivering the
Berlin: Springer; 2012. power of nanomedicine to patients today. J Control Release.
51. Blanco E, Hsiao A, Mann AP, Landry MG, Meric-Bernstam F, 2020;326:164-171.
Ferrari M. Nanomedicine in cancer therapy: Innovative doi: 10.1016/j.jconrel.2020.07.007
trends and prospects. Cancer Sci. 2011;102(7):1247-1252.
56. Rasmussen K, González M, Kearns P, Sintes JR, Rossi F,
doi: 10.1111/j.1349-7006.2011.01941.x Sayre P. Review of achievements of the OECD working party
52. Hassan SADH, Almaliki MNS, Hussein ZA, et al. on manufactured nanomaterials’ testing and assessment
Development of nanotechnology by artificial intelligence: programme: From exploratory testing to test guidelines.
A comprehensive review. J Nanostruct. 2023;13(4):915-932. Regul Toxicol Pharmacol. 2016;74:147-160.
doi: 10.22052/JNS.2023.04.002 doi: 10.1016/j.yrtph.2015.11.004

Volume 2 Issue 3 (2025) 58 doi: 10.36922/IMO025210024